Literature DB >> 23797590

The effects of antioxidants on gene expression following gamma-radiation (GR) and proton radiation (PR) in mice in vivo.

Niklas Finnberg1, Chris Wambi, Ann R Kennedy, Wafik S El-Deiry.   

Abstract

Ionizing radiation (IR) generates free radicals that interact randomly with a range of intracellular biomolecules that can result in lethal cellular injury. Therefore, IR-inflicted damage is a highly complex interplay of vastly different pathophysiological processes, including inflammation, epithelial regeneration, tissue remodeling, and fibrosis. The development of safe and effective radioprotectors that protect normal tissues following IR exposure is highly desirable. It was previously shown that dietary supplementation with an antioxidant (AOX) diet containing SeM (0.06 μg/g diet), α-lipoic acid (85.7 μg/g diet), NAC (171.4 μg/g diet), sodium ascorbate (142.8 μg/g diet), and vitamin E succinate (71.4μg/ g diet) was an effective countermeasure to lethality in mice following γ-radiation (GR) and proton radiation (PR). ( 1) (,) ( 2) Here we are examining the effect of the AOX diet on global gene expression following RBE-weighted doses of GR (7.0 Gy) and PR (6.4 Gy) in an attempt to gain further insight into the molecular mechanism of action of AOX diet in the context of radiation exposure. The AOX diet altered the expression pattern of several pro- and anti-apoptotic genes. Our data suggest that the AOX diet may alter IL6 signaling following GR and completely block the expression of the prokineticin PROK2, the ligand to the G protein-coupled receptors PROKR1 and PROKR2, which are involved in a number of pathophysiological processes.

Entities:  

Keywords:  IL6; PROK2; antioxidant; apoptosis; gamma-radiation; gene expression; in vivo; proton radiation; radiation

Year:  2013        PMID: 23797590      PMCID: PMC3755074          DOI: 10.4161/cc.25324

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  49 in total

1.  siRNA targeting NBS1 or XIAP increases radiation sensitivity of human cancer cells independent of TP53 status.

Authors:  Ken Ohnishi; Zorica Scuric; Robert H Schiestl; Noritomo Okamoto; Akihisa Takahashi; Takeo Ohnishi
Journal:  Radiat Res       Date:  2006-09       Impact factor: 2.841

2.  Effects of dietary supplements on space radiation-induced oxidative stress in Sprague-Dawley rats.

Authors:  Jun Guan; X Steven Wan; Zhaozong Zhou; Jeffrey Ware; Jeremiah J Donahue; John E Biaglow; Ann R Kennedy
Journal:  Radiat Res       Date:  2004-11       Impact factor: 2.841

3.  2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.

Authors:  Thomas J Smith; James Khatcheressian; Gary H Lyman; Howard Ozer; James O Armitage; Lodovico Balducci; Charles L Bennett; Scott B Cantor; Jeffrey Crawford; Scott J Cross; George Demetri; Christopher E Desch; Philip A Pizzo; Charles A Schiffer; Lee Schwartzberg; Mark R Somerfield; George Somlo; James C Wade; James L Wade; Rodger J Winn; Antoinette J Wozniak; Antonio C Wolff
Journal:  J Clin Oncol       Date:  2006-05-08       Impact factor: 44.544

4.  Tissue toxicity induced by ionizing radiation to the normal intestine: understanding the pathophysiological mechanisms to improve the medical management.

Authors:  M-C Vozenin-Brotons
Journal:  World J Gastroenterol       Date:  2007-06-14       Impact factor: 5.742

5.  A phase I clinical and pharmacology study using amifostine as a radioprotector in dose-escalated whole liver radiation therapy.

Authors:  Mary Feng; David E Smith; Daniel P Normolle; James A Knol; Charlie C Pan; Edgar Ben-Josef; Zheng Lu; Meihua R Feng; Jun Chen; William Ensminger; Theodore S Lawrence
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-03-21       Impact factor: 7.038

6.  Risk assessment for cancer induction after low- and high-LET therapeutic irradiation.

Authors:  H Engels; H G Menzel; P Pihet; A Wambersie
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

7.  Identification of granulocyte colony-stimulating factor and interleukin-6 as candidate biomarkers of CBLB502 efficacy as a medical radiation countermeasure.

Authors:  Vadim I Krivokrysenko; Alexander N Shakhov; Vijay K Singh; Frederick Bone; Yevgeniy Kononov; Inna Shyshynova; Alec Cheney; Ratan K Maitra; Andrei Purmal; Mark H Whitnall; Andrei V Gudkov; Elena Feinstein
Journal:  J Pharmacol Exp Ther       Date:  2012-07-26       Impact factor: 4.030

8.  Prokineticin-1: a novel mediator of the inflammatory response in third-trimester human placenta.

Authors:  Fiona C Denison; Sharon Battersby; Anne E King; Michael Szuber; Henry N Jabbour
Journal:  Endocrinology       Date:  2008-03-27       Impact factor: 4.736

9.  c-FLIP inhibits chemotherapy-induced colorectal cancer cell death.

Authors:  D B Longley; T R Wilson; M McEwan; W L Allen; U McDermott; L Galligan; P G Johnston
Journal:  Oncogene       Date:  2006-02-09       Impact factor: 9.867

10.  Ionizing radiation enhances IL-6 and IL-8 production by human endothelial cells.

Authors:  A V Meeren; J M Bertho; M Vandamme; M H Gaugler
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

View more
  1 in total

1.  Biological Effects of Space Radiation and Development of Effective Countermeasures.

Authors:  Ann R Kennedy
Journal:  Life Sci Space Res (Amst)       Date:  2014-04-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.